DMEPOS Mini-Series #6 – Therapeutic Shoes for Diabetes
According to the CDC, there are more than 130 million adults with diabetes or pre-diabetes in the United States. Every 17 seconds someone is diagnosed. Noridian, Jurisdiction D, has been conducting Targeted Probe and Educate reviews of HCPCS code A5500, which is for therapeutic shoes. The quarterly results based on dollars from April through June 2022 show an improper payment rate of 52%! Every other claim for therapeutic shoes is denied due to lack of medical necessity and/or technical reasons. CGS also shows a pre-pay review Quarterly Status report for the same date range with an error rate of 62%! Please review the guidance below for the required documentation to bill and dispense therapeutic shoes, and what the top denial reasons are for recoupment. Coverage Criteria (1 through 5) must be met, or claim will be denied. Documentation needed upon an audit: PAAS Tips:
- PAAS Defends Community Pharmacies by Engaging DME Medicare Administrative Contractor CGS - September 27, 2023
- Best Practices for Billing Vaginal Creams to Avoid Recoupment - September 23, 2023
- Migraine Medications Continue to Cause Headaches - August 24, 2023